SAVE THE DATE
Salon #3
28 July 2026
4pm CET, 3pm UK, 10am EST
Towards (self)regulation of ayahuasca ceremonies in Europe?
Floris Moerkamp
Although ayahuasca remains illegal in most countries, the interest in ceremonies continues to grow. In the Netherlands alone, around 320 facilitators administer more than 65.000 ayahuasca doses annually. While some participants travel abroad, the vast majority of Dutch ayahuasca consumption (87.6%) takes place domestically. The expansion of the ayahuasca retreat market raises legal, regulatory, and societal questions, including about safety, health risks, and facilitator training. And more fundamentally: should ayahuasca retreat centers be regulated under clearly defined conditions?
Floris Moerkamp will speak about recent developments in the European ayahuasca market. To facilitate well-informed debates about policy and regulation, he created an online portal that aims to collect input from relevant stakeholders. It will be presented and discussed, and all Saloners are warmly invited to provide input based on their specific expertise
SAVE THE DATE
Salon#4
29 September 2026
4pm CET, 3pm UK, 10am EST
Francisca Silva (PAREA)
https://parea.eu/
SAVE THE DATE
Salon #5
21 October 2026
4pm CET, 3pm UK, 10am EST
MDMA: Becond Ecstasy
On the report by the Dutch State Commission
Wim van den Brink
(vice chair of the Dutch State Commission on MDMA)
https://www.government.nl/documents/2024/05/31/mdma-beyond-ecstasy
SAVE THE DATE
Salon#6:
18 November 2026
4pm CET, 3pm UK, 10am EST
Psychedelic Governance as a Category Error in Mental Health Policy
Manal Al-Hammadi
Archiv
Salon#2:
10 June 2026
4pm CET, 3pm UK, 10am EST
A regulatory sandbox for psychedelics
Christoph Bublitz
The input will present ideas for a future regulatory framework for psychedelic-assisted medicine that responds to some of the challenges raised in the MDMA-AT approval process, at conferences, and in the literature, such as: the unspecific labelling of the drug; the combination of drug and therapy, which fall under quite different legal regimes; and novel risks arising from psychedelic effects in the absence of clear ethical guidance. The proposed solution is a so-called regulatory sandbox — a temporary and adaptive regulatory system to bridge the period until problems are better understood, best practices have been established, and ethical norms consolidated.
Archiv
Salon#1
6 May 2026
4pm CET, 3pm UK, 10am EST
From Prohibition to Rational Regulation: The Czech Drug Policy Experiment and a Blueprint for Reform.
Jitka Nykodemová
The talk is followed by a general discussion among saloners on the state of the field of psychedelics and law. Psychedelics and the Law: Where Are We Now & Where Are We Going?
The talk presents the Czech Republic’s pioneering legislative reforms in drug policy – including the strictly regulated legal market for non-medical psychoactive substances (“psychomodulatory substances”), cannabis legalisation progress, and medical psilocybin – as a concrete, replicable alternative to the global prohibition paradigm. It examines how evidence-based, human rights-grounded approaches were translated into national law within existing international legal frameworks, and what other countries and EU Member States can draw from this example.